bf/NASDAQ:REGN_icon.jpeg

COM:REGENERON

Regeneron Pharmaceuticals, Inc.

  • Stock

USD

Last Close

744.50

22/11 21:00

Market Cap

116.07B

Beta: -

Volume Today

1.03M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
2.10B
-
2.82B
33.96%
4.10B
45.55%
4.86B
18.44%
5.87B
20.82%
6.71B
14.28%
7.86B
17.18%
8.50B
8.06%
16.07B
89.14%
12.17B
24.26%
13.12B
7.76%
cost of revenue
155.35M
-
205.02M
31.97%
392.71M
91.55%
299.69M
23.69%
397.06M
32.49%
434.10M
9.33%
782.20M
80.19%
1.12B
43.17%
2.44B
117.65%
1.56B
35.98%
883.70M
43.37%
gross profit
1.95B
-
2.61B
34.12%
3.71B
41.94%
4.56B
22.90%
5.48B
20.05%
6.28B
14.64%
7.08B
12.82%
7.38B
4.18%
13.63B
84.82%
10.61B
22.16%
12.23B
15.27%
selling and marketing expenses
general and administrative expenses
329.42M
-
504.75M
53.23%
838.53M
66.13%
1.18B
40.45%
1.32B
12.12%
1.56B
17.86%
selling general and administrative expenses
329.42M
-
504.75M
53.23%
838.53M
66.13%
1.18B
40.45%
1.32B
12.12%
1.56B
17.86%
1.83B
17.90%
1.35B
26.64%
1.82B
35.58%
2.12B
15.95%
2.63B
24.36%
research and development expenses
859.95M
-
1.27B
47.84%
1.62B
27.47%
2.05B
26.64%
2.08B
1.11%
2.19B
5.35%
3.04B
38.90%
2.73B
9.93%
2.91B
6.33%
3.59B
23.53%
4.44B
23.56%
other expenses
-926K
-
-1.08M
16.63%
19.10M
1,868.52%
219.30M
1,048.17%
-280.40M
227.86%
-45.60M
83.74%
-89.90M
97.15%
cost and expenses
1.34B
-
1.98B
47.33%
2.85B
43.95%
3.53B
23.77%
3.79B
7.45%
4.18B
10.12%
5.65B
35.37%
4.92B
12.97%
7.12B
44.80%
7.18B
0.76%
7.95B
10.80%
operating expenses
1.19B
-
1.78B
49.33%
2.46B
38.45%
3.23B
31.35%
3.40B
5.13%
3.74B
10.21%
4.87B
30.17%
3.80B
21.98%
4.69B
23.33%
5.62B
19.86%
7.07B
25.84%
interest expense
46.44M
-
37.37M
19.52%
14.24M
61.89%
7.20M
49.48%
25.12M
249.12%
28.20M
12.27%
30.20M
7.09%
56.90M
88.41%
57.30M
0.70%
59.40M
3.66%
-73M
222.90%
ebitda
760.03M
-
838.43M
10.32%
1.25B
49.32%
1.33B
6.30%
2.08B
56.27%
2.53B
21.87%
2.21B
12.81%
3.87B
75.01%
9.38B
142.63%
5.17B
44.87%
4.05B
21.77%
operating income
760.03M
-
838.43M
10.32%
1.25B
49.32%
1.33B
6.30%
2.08B
56.27%
2.53B
21.87%
2.21B
12.81%
3.58B
61.85%
8.95B
150.15%
4.74B
47.03%
4.05B
14.60%
depreciation and amortization
41.20M
-
52.69M
27.87%
74.91M
42.18%
104.75M
39.83%
145.47M
38.88%
148.20M
1.88%
210.30M
41.90%
290.70M
38.23%
436.30M
50.09%
434.40M
0.44%
total other income expenses net
-231K
-
-25.31M
10,857.58%
-12.58M
50.31%
-926K
92.64%
-1.08M
16.63%
19.10M
1,868.52%
219.30M
1,048.17%
233.80M
6.61%
379M
62.10%
119.90M
68.36%
152.20M
26.94%
income before tax
713.36M
-
775.75M
8.75%
1.23B
57.92%
1.33B
8.55%
2.08B
56.30%
2.55B
22.85%
2.43B
4.87%
3.81B
56.86%
9.33B
144.75%
4.86B
47.90%
4.20B
13.57%
income tax expense
289.00M
-
427.67M
47.98%
589.04M
37.73%
434.29M
26.27%
880M
102.63%
109.10M
87.60%
313.30M
187.17%
297.20M
5.14%
1.25B
320.76%
520.40M
58.38%
245.70M
52.79%
net income
424.36M
-
348.07M
17.98%
636.06M
82.74%
895.52M
40.79%
1.20B
33.83%
2.44B
103.95%
2.12B
13.44%
3.51B
66.05%
8.08B
129.86%
4.34B
46.28%
3.95B
8.87%
weighted average shs out
97.92M
-
100.61M
2.75%
103.06M
2.43%
104.72M
1.61%
106.34M
1.55%
107.90M
1.47%
109.20M
1.20%
107.60M
1.47%
105.70M
1.77%
107.10M
1.32%
106.70M
0.37%
weighted average shs out dil
111.29M
-
113.41M
1.91%
115.23M
1.60%
116.37M
0.99%
115.95M
0.35%
114.80M
1.00%
114.60M
0.17%
115.10M
0.44%
112.20M
2.52%
113.50M
1.16%
113.70M
0.18%
eps
4.33
-
3.46
20.09%
6.17
78.32%
8.55
38.57%
11.27
31.81%
22.65
100.98%
19.38
14.44%
32.65
68.47%
76.40
134.00%
40.51
46.98%
37.05
8.54%
epsdiluted
3.81
-
3.07
19.42%
5.52
79.80%
7.70
39.49%
10.34
34.29%
21.29
105.90%
18.46
13.29%
30.52
65.33%
71.97
135.81%
38.22
46.89%
34.77
9.03%

All numbers in USD (except ratios and percentages)